Valtech Cardio Raises $17.8 Million
Valtech Cardio Ltd., an Israel-based developer of minimally-invasive surgical and transcatheter mitral valve repair and replacement technologies, has raised $17.8 million in Series B funding. Undisclosed new investors were joined by return backers OXO Capital Valve Ventures, NGN Biomed and Peregrine VC.
2 February 2010•2 mins read
